Bond CignaCorp 5.4% ( US125523CS74 ) in USD

Issuer	CignaCorp
Market price	105.003 % ▲
Country	United States
ISIN code	US125523CS74 ( in USD )
Interest rate	5.4% per year ( payment 2 times a year)
Maturity	15/03/2033
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	2 000 USD
Total amount	800 000 000 USD
Cusip	125523CS7
Standard & Poor's ( S&P ) rating	A- ( Upper medium grade - Investment-grade )
Moody's rating	Baa1 ( Lower medium grade - Investment-grade )
Next Coupon	15/09/2026 ( In 166 days )
Detailed description	Cigna Corporation is a global health service company offering medical, dental, behavioral health, pharmacy, vision, and other related products and services through various subsidiaries in numerous countries. A detailed analysis of a significant fixed-income offering reveals key insights into the financial landscape of a prominent US-based entity. This particular bond, identified by the ISIN US125523CS74 and CUSIP 125523CS7, is an obligation issued by Cigna Group, a leading global health services company headquartered in the United States. Cigna Group operates as a diversified health service organization, primarily engaged in offering medical, dental, disability, life, and accident insurance and related products and services to individuals, employers, and government entities. Through its various segments, including Evernorth and Cigna Healthcare, the company provides comprehensive health benefits, pharmacy benefits management, and care solutions, serving millions of customers worldwide and solidifying its position as a major player in the evolving healthcare industry. The bond itself carries a coupon rate of 5.4%, denominated in US Dollars (USD), and is scheduled to mature on March 15, 2033. Interest payments are made semi-annually, reflecting a payment frequency of two times per year. The total issuance size for this instrument stands at a substantial USD 800,000,000, with a minimum purchase size set at USD 2,000, making it accessible to a range of institutional and qualified individual investors. Currently, the bond is trading on the market at 102.786% of its par value, indicating that its coupon rate is perceived as attractive relative to prevailing market interest rates or the issuer's credit standing. The creditworthiness of Cigna Group, as assessed by major independent rating agencies, underscores its robust financial health, with Standard & Poor's having assigned an 'A-' rating to the issuance, while Moody's has provided a 'Baa1' rating; both ratings fall within the investment-grade category, signifying a low to moderate credit risk and the issuer's strong capacity to meet its financial commitments, a testament to Cigna Group's stable operational performance, diversified business model, and prudent financial management within the competitive healthcare sector.